Top Killers in America
A study published in 2016 in the British Medical Journal (BMJ) identified “medical error” as the third leading cause of death in the United States. Study authors reported that medical errors are responsible for the deaths of about 251,000 Americans each year—up from the nearly 100,000 Americans estimated by the Institute of Medicine (IOM) in […]
WHO Declares Monkeypox a Global Health Emergency
On Aug. 14, 2024, the World Health Organization (WHO) declared monkeypox (mpox) a public health emergency of international concern (PHEIC). “Today, the Emergency Committee met and advised me that in its view, the situation constitutes a public health emergency of international concern. I have accepted that advice,” said WHO Director-General Tedros Adhanom Ghebreyesus,1 2 3 […]
Vaccines, Doses & Shots. Confused?
In a phone conversation with Robert F. Kennedy, Jr. regarding childhood vaccinations last month, Donald Trump said: When you feed a baby, Bobby, a vaccination that is, like, 38 different vaccines and it looks like it’s been for a horse. Not a, you know, 10-pound or 20-pound baby. And then you see the baby all […]
Vaccine Strain Poliovirus Detected in Gaza Sewage—WHO Sending a Million Doses of Polio Vaccine
In response to a statement last week by the Palestinian Ministry of Health declaring that the Gaza Strip is “epidemic area“ for polio, the World Health Organization (WHO) announced it will send more than one million doses of polio vaccine to be administered over the next few weeks even though the poliovirus detected in Palestine […]
Nearing the Unthinkable Scenario of 1 in 2 Children With Autism in the U.S.
The prevalence for autism spectrum disorder (ASD) among eight-year-old children in the United States reached 1 in 36 last year. At least, that’s the rate that was confirmed by an analysis published in the U.S. Centers for Disease Control and Prevention’s (CDC) epidemiological digest Morbidity and Mortality Weekly Report (MMWR) on Mar. 24, 2023. That […]
FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine
On June 17, 2024, the U.S. Food and Drug Administration (FDA) licensed Merck & Company, Inc.’s new pneumococcal conjugate vaccine Capvaxive (formerly V116) for adults 18 years of age and older. The vaccine is designed to protect against 21 types of the bacteria causing pneumococcal disease, which can lead to severe infection in the lungs […]